King of Prussia, PA, United States of America

Louis F D'Andrea


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 132(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Louis F D'Andrea**

Introduction

Louis F D'Andrea, an accomplished inventor based in King of Prussia, PA, has made significant contributions to the pharmaceutical industry. Known for his innovative approach, he holds two patents that focus on enteric film-coating compositions, which are crucial for the effective delivery of pharmaceutical tablets.

Latest Patents

D'Andrea's latest patents involve a non-toxic edible enteric film coating, consisting of both a dry powder and an aqueous suspension specifically designed for coating pharmaceutical tablets. His inventions include not only the enteric coated tablets but also detailed methods for creating both the dry powder and aqueous coating suspension. These advancements facilitate the effective coating of tablets, ensuring that they can safely and effectively deliver their active ingredients to the intended site in the gastrointestinal tract.

Career Highlights

Louis F D'Andrea currently works with Colorcon Incorporated, a company renowned for its expertise in pharmaceutical coatings and delivery systems. His work at Colorcon underscores his commitment to advancing the efficacy of drug formulations, helping to enhance patient safety and compliance through innovative solutions.

Collaborations

Throughout his career, D'Andrea has collaborated with notable colleagues, including Stuart C Porter and Edward J Woznicki. These partnerships have fostered an environment of creativity and shared expertise, leading to the successful development of cutting-edge technologies in the field of pharmaceutical coatings.

Conclusion

In summary, Louis F D'Andrea exemplifies the spirit of innovation through his work in developing enteric film-coating compositions. His patents not only enhance the pharmaceutical industry's capabilities but also demonstrate the ongoing need for innovation in drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…